Biogen Inc. (NASDAQ:BIIB) Q2 2023 Earnings Call Transcript
Operator: Good morning. My name is Ruth and I'll be your conference operator today.
Stay updated with breaking news from Priya Singhal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good morning. My name is Ruth and I'll be your conference operator today.
Biotech giant's cost-cutting effort comes amid the launch of its Alzheimer's treatment, Leqembi.
BIIB earnings call for the period ending June 30, 2023.
Biogen Inc. (NASDAQ:BIIB – Free Report) insider Priya Singhal sold 81 shares of the firm’s stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $282.87, for a total transaction of $22,912.47. Following the sale, the insider now owns 2,924 shares in the company, valued at $827,111.88. The […]
Grimes & Company Inc. trimmed its stake in Biogen Inc. (NASDAQ:BIIB – Free Report) by 3.4% in the 1st quarter, HoldingsChannel reports. The fund owned 44,488 shares of the biotechnology company’s stock after selling 1,547 shares during the quarter. Grimes & Company Inc.’s holdings in Biogen were worth $12,369,000 as of its most recent SEC […]